What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Endocrinology
Rainer H. Böger mostly deals with Internal medicine, Endocrinology, Asymmetric dimethylarginine, Nitric oxide and Endothelium.
He works mostly in the field of Internal medicine, limiting it down to concerns involving Diabetes mellitus and, occasionally, Heart failure.
His Endocrinology research incorporates elements of Inflammation and Stroke.
His biological study spans a wide range of topics, including Chromatography, Endogeny, End stage renal disease and Risk factor.
His Nitric oxide research integrates issues from Biochemistry, Vascular disease and Citrulline.
His research in Endothelium intersects with topics in Endothelial stem cell, Disease and Cell biology.
His most cited work include:
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction Its Role in Hypercholesterolemia (1089 citations)
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study (945 citations)
- Opioids and the management of chronic severe pain in the elderly: Consensus statement of an international expert panel with focus on the six clinically most often used world health organization step III opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone) (595 citations)
What are the main themes of his work throughout his whole career to date?
Rainer H. Böger mainly investigates Internal medicine, Endocrinology, Asymmetric dimethylarginine, Nitric oxide and Cardiology.
His Internal medicine research focuses on Diabetes mellitus and how it relates to Body mass index.
His work on Endocrinology is being expanded to include thematically relevant topics such as Disease.
His studies in Asymmetric dimethylarginine integrate themes in fields like Heart failure, Endogeny, Pharmacology, Cohort and Risk factor.
The various areas that he examines in his Nitric oxide study include Hypoxia, Vasodilation, Biochemistry, Pulmonary hypertension and Citrulline.
The Cardiology study combines topics in areas such as Hazard ratio and Confidence interval.
He most often published in these fields:
- Internal medicine (77.06%)
- Endocrinology (56.27%)
- Asymmetric dimethylarginine (47.67%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (77.06%)
- Asymmetric dimethylarginine (47.67%)
- Endocrinology (56.27%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Asymmetric dimethylarginine, Endocrinology, Cardiology and Nitric oxide.
The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways.
His research integrates issues of Nitric oxide synthase, Hypoxia, Pulmonary hypertension, Pathophysiology and Vasodilation in his study of Asymmetric dimethylarginine.
His work carried out in the field of Endocrinology brings together such families of science as Intima-media thickness and Arginase.
Endothelium and Adverse effect is closely connected to Prospective cohort study in his research, which is encompassed under the umbrella topic of Cardiology.
His Nitric oxide research includes themes of Inflammation and Sepsis.
Between 2015 and 2021, his most popular works were:
- Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. (39 citations)
- Markers of nitric oxide are associated with sepsis severity: an observational study (29 citations)
- Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension? (28 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
Rainer H. Böger spends much of his time researching Internal medicine, Asymmetric dimethylarginine, Endocrinology, Nitric oxide and Cardiology.
In Internal medicine, Rainer H. Böger works on issues like Surgery, which are connected to Peripheral blood mononuclear cell and Severity of illness.
His Asymmetric dimethylarginine study combines topics from a wide range of disciplines, such as Hypoxia, Pulmonary hypertension, Effects of high altitude on humans, Pathophysiology and Vasodilation.
His work on Nitric oxide synthase, Kidney disease and Omega-N-Methylarginine as part of general Endocrinology research is frequently linked to Percentile, bridging the gap between disciplines.
Rainer H. Böger combines subjects such as Sepsis, Ventricular hypertrophy, Cardiac function curve, Fibrosis and Muscle hypertrophy with his study of Nitric oxide.
His Cardiology research is multidisciplinary, incorporating perspectives in Prospective cohort study, Cerebrospinal fluid and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
